Market Checkup: Obesity
In this edition of The Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss emerging treatments for obesity. From Mayor Bloomberg's controversial soda ban in New York to new medications just hitting the market, this continues to be a hotly debated disease.
It's no secret that biotech stocks have been soaring recently, but the best investment strategy is to pick great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" not only shares stocks that could help you build long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today.
The article Market Checkup: Obesity originally appeared on Fool.com.David Williamson owns shares of Coca-Cola. Max Macaluso, Ph.D. owns shares of Starbucks. The Motley Fool recommends Coca-Cola, Johnson & Johnson, McDonald's, PepsiCo, and Starbucks and owns shares of Johnson & Johnson, McDonald's, PepsiCo, and Starbucks. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.